Arrowhead Pharmaceuticals, Inc. (LON:0HI3)

Revenue

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
GSK Revenue	5.33M	2.69M	Log In	Log In	Log In
Horizon Revenue	-	-	Log In	Log In	Log In
Takeda Revenue	-	866.00K	Log In	Log In	Log In
Janssen Revenue	-	-	Log In	Log In	Log In
Amgen Revenue	-	-	Log In	Log In	Log In
Revenue (Total)	-	3.55M	Log In	Log In	Log In

Updated Jun 30, 2025. Data Source: Fiscal.ai.